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The American Journal of Pathology, the official journal of the American
Society for Investigative Pathology (ASIP), seeks to publish high-quality original
papers on the cellular and molecular biology of disease. The Editors accept
manuscripts that advance basic and translational knowledge of the pathogenesis,
classification, diagnosis, and mechanisms of disease, without preference for a
specific analytic method. High priority is given to studies on human disease and
relevant experimental models using cellular, molecular, animal, biological, chem-
ical, and immunological approaches in conjunction with morphology.
Manuscript Categories. Regular Articles are categorized in the Table of
Contents according to the following research topics: Biomarkers, Genomics, Pro-
teomics, and Gene Regulation; Biophysical Imaging and Computational Biology;
Cardiovascular, Pulmonary and Renal Pathology; Cell Injury, Repair, Aging and
Apoptosis; Epithelial and Mesenchymal Cell Biology; Gastrointestinal, Hepatobili-
ary and Pancreatic Pathology; Growth Factors, Cytokines, Cell Cycle Molecules;
Immunopathology and Infectious Diseases; Matrix Pathobiology; Metabolic, En-
docrine and Genitourinary Pathobiology; Molecular Pathogenesis of Genetic and
Inherited Diseases; Musculoskeletal Pathology; Neurobiology; Stem Cells, Tissue
Engineering and Hematopoietic Elements; Tumorigenesis and Neoplastic Pro-
gression; and Vascular Biology, Atherosclerosis and Endothelium Biology. Not all
topic areas will appear in each issue, as this is dependent on the content of original
research accepted for publication. Upon acceptance, authors will be asked for
their preference of topic category assignment; however, the Editors will make the
final determination regarding topic category placement.
Short Communications are intended to provide a forum for the rapid publication
of timely and significant findings, in brief. Manuscripts in this category should be
concise but definitive, may bemore descriptive and lessmechanistic than Regular
Articles, and must not exceed 12 double-spaced typed pages (excluding refer-
ences and legends) and a maximum of 3 to 4 figures and tables. Categorization
of manuscripts in this category is at the Editor’s discretion.
In addition to original research articles, the Journal publishes articles categorized
as Reviews, Mini-Reviews, Biolological Perspectives, and Commentaries.
Authors whowish to publish a Review orMini-Review should send their curriculum
vitae along with an outline of the proposed article for prior approval by the
Editor-in-Chief. Reviews have a maximum of 6,000 words, 100 references, and 4
tables or figures (one of which is mechanistic);Mini-Reviews have a maximum of
4,000 words, 50 references, and 2 tables or figures (one of which is mechanistic).
Biological Perspectives are submitted by invitation only and provide stream-
lined, mechanistic insight into the current state of research in the discussed topic.
Commentaries are submitted by invitation only and relate to a concurrently
published manuscript. All invited papers are subject to the same review process
as unsolicited articles.
Review Process. The Editors perform an initial evaluation on all submissions
to determine whether they believe the manuscript will achieve a sufficient priority
score to warrant publication. Priority is determined by the Editors’ assessment of
the manuscript relative to other papers being considered. The aim is that expe-
ditious treatment will enable authors to submit their manuscript elsewhere as soon
as possible without suffering unnecessary delays. For manuscripts accepted for
external review, the Editor-in-Chief assigns manuscripts to Associate Editors
according to their expertise. The Associate Editor will solicit reviewers (typically,
two external reviews are sought). Authors are encouraged to identify up to five
potential reviewers. Authors may also request that specific reviewers not be used
due to prior collaborations, known conflicts of interest, or direct competition. The
Editors will make every effort to respect requests that are well-founded; however,
the Editors do have the authority to utilize such a reviewer if it is necessary for
expert peer review. It is the practice of the Journal to conduct a blinded peer-
review process. The peer-review process is kept completely confidential; it is con-
sidered a violation of this confidentiality for authors to identify or attempt to commu-
nicate directly with peer reviewers or Associate Editors regarding their manuscript.
The reviewer comments and Associate Editor’s recommendation are evaluated by
the Editor-in-Chief for disposition and transmittal to the authors. Every effort is made
to complete the review process within 35 days of the date received.
Review Decisions. Only a portion of manuscripts will be accepted for publi-
cation. A number of worthy manuscripts will be rejected based on priority. The
Journal will advise authors whether the manuscript is accepted, acceptable with
revisions, rejected but encourage resubmission (after major revision), or rejected.
A manuscript may be returned to the authors without outside review if the Editors
find it inappropriate for publication in this Journal. Appeals (rebuttals) to editorial
decisions must be submitted within 60 days to be considered.
Journal Scientific Integrity Policy. The Journal has developed principles
for defining scientific misconduct as well as procedures for handling such matters.
General guidelines are described below; detailed information can be viewed at
http://ajp.amjpathol.org. To report suspected misconduct relating to authors, re-
viewers, or Editors, send written complaint to the Editorial Office at The American
Journal of Pathology, 9650 Rockville Pike, Bethesda, Maryland, USA 20814-3993
or ajp@asip.org. Issues relating to staff conduct should be directed to the ASIP
Executive Officer at American Society for Investigative Pathology, 9650 Rockville
Pike, Bethesda, Maryland, USA 20814-3993 or mesobel@asip.org.
Author Conduct. Authorship is defined as 1) substantial contributions to con-
ception and design, or acquisition of data, or analysis and interpretation of data; 2)
drafting the manuscript or revising it critically for important intellectual content; and
3) final approval of the version to be published. Authors should meet conditions 1,
2, and 3. When submitting a manuscript to the Journal, the corresponding author
takes responsibility on behalf of all authors for the authorship, authenticity and
integrity of the research being reported. Authors should take special care that
manuscripts submitted to the Journal are prepared in accordance with the Uniform
Requirements for Manuscripts Submitted to Biomedical Journals (see http://www.
icmje.org); in particular the ethical considerations regarding authorship, conflicts of
interest, redundant publication and treatment and confidentiality of research sub-
jects should be carefully adhered to. Additionally, the Journal takes great care to
secure the confidentiality and integrity of the peer-review process; it is considered
a violation of this confidentiality for authors to identify or attempt to communicate
directly with peer reviewers or Associate Editors regarding their manuscript. The
Editors will consider any deliberate ethical violation in either the reported research
or the manuscript preparation and review to be actionable misconduct, the po-
tential results of which may be manuscript rejection or public article retraction,
reporting of conduct to the authors’ governing institutions, and/or the denial to
consider any future submissions to the Journal. Willful misconduct does not
include incidents of honest misjudgment or inadvertent error. Detailed information
regarding possible misconduct can be found in the Journal Scientific Integrity
Policy at http://ajp.amjpathol.org.
Manuscript Submission. Manuscripts should be submitted online via the
Rapid Review system (http://www.rapidreview.com/ASIP2/CALogon.jsp). De-
tailed instructions on preparing and submitting files can be found on the author
submission website at the above URL. Authors having difficulty submitting files
online should complete the online submission form on Rapid Review to receive
the assigned manuscript number. With the manuscript number clearly noted,
electronic files (manuscript text, figures, and tables) should be emailed to the
Editorial Office at ajp@asip.org or sent on disk by mail to: Michael P. Lisanti,
M.D., Ph.D., Editor-in-Chief, The American Journal of Pathology, 9650 Rock-
ville Pike, Bethesda, Maryland, USA 20814-3993. The cover letter must state
any conflicts of interest (both financial and personal), affirm that the manuscript
has not been published previously and is not being considered concurrently by
another publication, and affirm that all authors and acknowledged contributors
have read and approved the manuscript. Submissions will be ineligible for review
if previously published in any form (print or online) other than as an abstract. This
includes any public posting of raw manuscripts or pre-reviewed material.
A non-refundable manuscript processing fee of U.S. $50 is required with submis-
sion. This fee should be paid electronically at the time of submission. Manuscripts
arising from research in developing countries may be eligible for waiver of the
submission fee only if all authors are located in a qualifying country (waiver must
be applied for at time of submission; for a list of eligible countries, see Band 1 and
2 eligible countries at http://www.who.int/hinari/eligibility/en/). Otherwise, manu-
script submission fees will not be waived.
Manuscript Preparation. Manuscripts should be prepared in the style of the
Journal and in accordance with The Uniform Requirements for Manuscripts Sub-
mitted to Biomedical Journals (see http://www.icmje.org). The preferred file format
for text is MSWord. Standard abbreviations can be found in the CSEStyleManual
(7th ed., 2006). All pages of the manuscript should be double-spaced and num-
bered (including references, tables and figure legends). Other formatting specifi-
cations (eg, font size and type, margin settings, etc.) are left to the authors’
discretion, as papers accepted for publication will be reformatted according to the
print specifications of the Journal. Manuscripts not prepared in accordance with
the submission guidelines detailed below may be returned to the authors. Authors
are encouraged to include a list of nonstandard abbreviations to aid reviewers;
however, the Journal does not publish abbreviations or keywords as part of the
final article. In addition, authors should be ready to comply with Editors’ requests
for copies of any similar works in preparation, copies of cited manuscripts that are
submitted or in press, and/or supporting manuscript data (eg, data not shown but
summarized in the manuscript) that may aid the review process.
Title Page. The title page must include a concise title accurately reflecting the
findings of the work; full names (not initials) of all authors; department, institution
and address where the research was performed; number of text pages, tables and
figures; a short running head (40 characters or less); grant numbers and sources
of support; and name, address, phone, fax, and email of the corresponding author;
name and address of author who should receive reprint requests. If an author
changes employment after the study was performed, the new affiliation informa-
tion for that author should be included as a footnote. Any affiliations (eg, employ-
ment, consultancies, board membership, stock ownership, funding, honoraria,
expert testimony, patents or royalties, travel reimbursements, industry-supplied
free reagents, etc) with any organization or entity having a direct financial or
personal interest in the subject matter or materials discussed in the article should
also be clearly stated.
Abstract. An abstract of 220 words or less should be prepared on a separate
sheet and should be intelligible to the general reader without reference to the text.
The abstract should clearly summarize the background, methodology, results,
and significance of the study. Abbreviations and citations should be avoided.
Text. The remaining sections of the text, which should include Introduction,
Materials and Methods, Results, Discussion, and Acknowledgments (in this or-
der), need not begin on new pages. Commonly-abbreviated terms should be
spelled out in their first occurrence and then may be referenced in abbreviation
through the remainder of the manuscript. Consult the Human Genome Organisa-
tion Gene Nomenclature Committee website (http://www.genenames.org/) for
gene names and symbols. For a complete list of other approved nomenclature
organizations (eg, bacteria, viruses, mice), please contact the Editorial Office.
ForMaterials andMethods, authors should describe experimental and statistical
methods in enough detail that other researchers can replicate results and evaluate
claims. In general, inclusion of method or reagent details as supplementary
material is not acceptable. The sequences of oligonucleotides, if not previously
published, should be provided. Novel DNA or protein sequences should be de-
posited to an appropriate database (eg, Genbank, EMBL, SWISS-PROT), with
the accession numbers included in the manuscript. When providing supplier
information for materials sources, company name and location (city and state, or
city and country) should be provided. Website references to company information
are not permitted. All novel materials and the procedures to prepare them should
be described in sufficient detail to allow their reproduction (eg, DNA constructs,
analytical software). Materials that are approved for investigational-use only
should be clearly indicated. Publication in the Journal implies that the authors
agree, upon reasonable request, to share any materials or data that are integral to
the results presented in the article, including whatever would be necessary for a
skilled investigator to verify or replicate the claims. Authors must disclose upon
submission any restrictions on the availability of materials or information, such as
for patented or dual-purpose materials.
Reporting guidelines for specific study designs (eg, randomized controlled trials)
can be found in the Uniform Requirements for Manuscripts Submitted to Biomed-
ical Journals (see http://www.icmje.org). Authors must affirm that the research
protocol was approved by the appropriate institutional review boards or ethics
committees for human (including use of human cells or tissues) or animal exper-
iments and that all human subjects provided appropriate informed consent and/or
that regulations concerning the use of animals in research were adhered to. If
race/ethnicity is reported, authors should state who determined race/ethnicity,
how the options were defined, and why race/ethnicity was important in the study.
Authors should be prepared to provide study protocol number(s) if requested.
Authors should obtain permission from all individuals named (by full name) in the
Acknowledgments who contributed substantially to the work reported (eg, data
collection, analysis, or writing/editing assistance) but did not fulfill the authorship
criteria. Likewise, authors should receive permission from all individuals named as
sources for personal communication or unpublished data. Such permissions
should be affirmed by the corresponding author in the cover letter.
References. References should begin on a new page, be double-spaced and
numbered in order of citation in the text, including citations in tables and figure
legends. Complete author citation is required (use of “et al” is not acceptable).
References should conform to the style of the Journal. Examples follow:
Journals: Cecena G, Wen F, Cardiff RD, Oshima RG: Differential sensitivity of
mouse epithelial tissues to the polyomavirus middle T oncogene. Am J Pathol
2006, 168:310–320
Books: Fishman AP: Pulmonary Hypertension and Cor Pulmonale. Pulmonary
Diseases and Disorders. Edited by Fishman AP. New York, McGraw-Hill, 1988,
pp. 999–1048
In press: To be used only for papers accepted for publication. Cite as for journal
with (in press) in place of volume and page numbers. Include digital object
identifier (doi) when available for online early publications.
Submitted papers/unpublished data: Cite in text only.
Web sites:Cite in text only. SeeData Supplements section below for proper use
of web site references. Use the doi when available. Include the name of the
institution sponsoring the web site, URL address with direct linkage to the refer-
enced information, and date of access.
Tables. Tables should be typed double-spaced and submitted after the main text
on separate pages, as part of the manuscript. The preferred file format for Tables
is MS Word; figure file formats (including those embedded in the text) are unac-
ceptable. Tables should be black and white text only and should not include
figures or other non-typeset images. Color or gray shading is not permitted.
Emphasis may be represented by bold, italics, and underlining. Table footnotes
should use the following sequential symbols: *, †, ‡, §, ¶, ; these may be doubled
up if needed. All symbols and abbreviations in the table should be defined in the
footnotes.
Figures. Authors should give considerable care in preparing figures. Resolution
and quality of submitted images is the responsibility of the author; as a routine, the
Journal does not provide figure enhancement services. Images (such as graphs
and schematics) should have a white background; color, black, or gray is gener-
ally unacceptable. Authors are encouraged to carefully consider whether bar or
line graphs should be submitted in grayscale or color, paying special attention to
the ability of a reader to distinguish between different data points. Figures may
consist of multiple related panels (labeled A, B, C, etc.) described under one figure
legend. Each figure (with all of its related panels) should be arranged on a single
page as it should appear in final publication. Figure labels should appear in the
upper left corner as uppercase letters; refrain from using sub-labels (Aa, Ab, Ai,
Aii, A1, A2, etc) or titles for each panel label; panels should be labeled chrono-
logically from left to right. Figure panels submitted on separate pages will be
arranged at the publisher’s discretion. If figures are to be published in black and
white, they should be submitted for review in black and white. When preparing
composite figures, the front side of individual parts should be clearly and properly
labeled. Figures should be sized to fit one column (8 cm) or two columns (17 cm).
Maximum page length is 22.5 cm. Figures deviating from these dimensions will be
sized at the publisher’s discretion. Unwanted background material should be
excluded, and edges should be straight.
Preparation of Images (Ethics): Taking photographs under varied fields of
view, light intensity, magnifications, or contrast conditions without disclosing that
the data are not unique to the present study constitutes suspect scientific conduct.
Further, unless serial sections are used, the publication of identical-appearing
images labeled with different staining techniques in different papers raises legiti-
mate questions. Finally, reuse of one’s data (ie, “self-plagiarism”) is a copyright
violation if the authors signed over copyright to the publisher; the reuse of such
copyrighted images is at the sole discretion of the publisher, with proper attribution
of the original publication a requirement of reuse. No specific feature within an
image may be enhanced, obscured, moved, removed, or introduced. The group-
ing of images from different parts of the same gel or blot, or from different gels or
blots, fields, or exposures must be made explicit by the arrangement of the figure
(eg, using dividing lines) and in the figure legend. Adjustments of brightness,
contrast, or color balance are acceptable only if they are applied to the whole
image, whether experimental or control image, and as long as they do not obscure
or eliminate any information present in the original (Portions adapted with permis-
sion from the JCB). Any evidence of inappropriate manipulation may prompt the
Editors to request an explanation and access to original data, which the authors
must make available. Information can be found in the Journal Scientific Integrity
Policy at http://ajp.amjpathol.org.
Digital Art:Digital figure files are required for submission. The American Journal
of Pathology’s requirement for color images is RGB (Red, Green, Blue) color
mode. Images submitted in RGBwill retain the vivid reds, greens, and blues of the
original digital files for online publication. Authors should therefore submit all
figures (for both new and revised manuscripts) in the RGB color mode. The
preferred file formats for digital figures are PDF, TIFF, and EPS. For detailed
instruction on preparing digital art for submission or production, visit http://www.
elsevier.com/wps/find/authorsview.authors/authorartworkinstructions.
Figure Legends. Figure legends should be submitted as part of the manuscript
(separate from the figure files) and should describe any staining method and
degree of magnification. If the exact scale is critical, scale bars should be used on
the photograph and specified in the legend. Figure legends should adequately
describe all descriptors: arrows, arrowheads, scale bars, insets, asterisks, boxes/
circles/etc in line graphs, and any other notations. Descriptive text, rather than
graphics inserted into the text, should be used when possible (eg, closed circles,
open boxes, hatched bars, etc); alternatively, a legend key should be included in
the figure. Statistical significance (eg, P values) should be clearly defined by
asterisks (*, **, ***) or by other sequential symbols: *, †, ‡, §, ¶, ; these may be
doubled up if needed. All abbreviations should also be defined.
Data Supplements and Non-Traditional Media. Figures and tables that
are critical to the evaluation and understanding of the research presented, but
which cannot be accommodated via the print medium (eg, video), will be consid-
ered part of the manuscript submission and will be published on the Journal
website if the manuscript is accepted. Supplemental figures, tables, and legends
should be prepared as above. Supplemental material published on the Journal
website is subject to the same copyright as applies to the printed article. Online
data will remain associated with its article and is not subject to any modifications
or updates after publication. Authors of accepted manuscripts will be charged $95
per supplemental data file to be published on the Journal website (up to 1MB; files
over 1MB will be charged an additional $95 per megabyte). Authors are therefore
encouraged to minimize the size of their supplemental data files.
Complex data sets such as microarray data and gene sequences should be
deposited in a reliable public archive. Microarray repositories should comply with
the Minimum Information About a Microarray Experiment (MIAME) guidelines
(http://www.mged.org/Workgroups/MIAME/miame_1.1.html). Examples include
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and Array Express
(http://www.ebi.ac.uk/arrayexpress/). Tissue microarray data exchange specifica-
tions can be found at http://www.biomedcentral.com/1472-6947/3/5. Otherwise,
the data may be published as supplemental data on the Journal’s website (http://
ajp.amjpathol.org).
Other materials that are not required to understand and evaluate the article may
be stored on an institutional website and referenced as a URL within the manu-
script text. In this case, the authors must assume responsibility for maintaining a
live, unrestricted link to the material from the URL published within the article, in
perpetuity. Failure to maintain a live, unrestricted link may result in retraction of the
article by the Editors. Material that has been published previously (print or online)
is not acceptable for posting as supplementary data. Instead, the appropriate
reference(s) to the original publication should be made in the text and references.
The Editors will make the final determination as to whether a given data set is
essential to the manuscript and whether they will require publication of the mate-
rial on the Journal website. Failure to relinquish required materials for online
publication can result in the reversal of a manuscript’s acceptance.
Copyright. Copyright of published manuscripts is held by the American Society
for Investigative Pathology, which must receive the assignment of copyright from
the authors of accepted manuscripts. For US government employees, the above
assignment applies only to the extent allowable by law. For detail, see http://www.
asip.org/pubs/ajprights.pdf.
Publishing in The American Journal of Pathology automatically places authors in
compliance with NIH Public Access Policy (see http://publicaccess.nih.gov/
submit_process.htm, SubmissionMethod A). Any article noted as being funded by
NIH, HHMI, Wellcome Trust, or MRC is deposited in PubMed Central, to be made
available to the public twelve months after final print publication (unless the
funding agency stipulates a sooner release date). Authors therefore should NOT
complete a separate deposit of their material but will be contacted by PubMed
Central for grant verification once the article has been received by the PMC article
system. For information on how to cite articles in NIH grant applications, plaese
visit http://www.asip.org/pubs/AuthorNotice.htm.
Contact the healthpermissions@elsevier.com regarding permission to deposit
manuscripts in other government-sponsored repositories in cases where The
American Journal of Pathology does not have a system in place to automatically
deposit materials on behalf of their authors. Deposit of accepted or published
manuscripts in any non-AJP repository without prior permission is a violation of
copyright.
Embargo Policy. All information regarding the content of submitted or ac-
cepted manuscripts is strictly confidential. Information contained in or about ac-
cepted articles cannot appear in print, audio, video, or digital form or be released
by the news media until the Journal embargo date has passed, not to exceed the
publication date of the article. For detailed information on embargo release dates
or for news media requests for preprint copies of specific articles, contact
asipproduction@elsevier.com.
Financial Disclosure andConflicts of Interest. All authors must disclose
any current or former affiliations (eg, employment, consultancies, board member-
ship, stock ownership, funding, honoraria, expert testimony, patents or royalties,
travel reimbursements, industry-supplied free reagents, etc) with any organization
or entity having a direct financial or personal interest in the subject matter or
materials discussed in the article. Authors should err on the side of full disclosure
and should contact the Editorial Office if they have questions or concerns. This
information should be provided at the time of submission and reiterated as part of
copyright assignment. Failure to do so may result in manuscript rejection or
editorial retraction of the article. Further information can be found in the Journal
Scientific Integrity Policy at http://ajp.amjpathol.org. Uponmanuscript acceptance,
all coauthors will be instructed to formally disclose all potential conflicts.
Publication Charges
Figure and Table Charges: Authors will be charged $550 per color figure, $50
per black & white or grayscale figure, and $50 per composed table, per printed
page (ie, figures or tables necessitating more than one printed page will incur an
additional charge). Corresponding authors of published manuscripts who are
current, dues-paying regular members of ASIP at the time of submission will
receive one free color figure as a benefit of membership; page charges will not be
waived for ASIP members.
Page Charges: Authors will be charged $95 per printed page. Manuscripts
arising from research in developing countries may be eligible for waiver of publi-
cation charges only if all authors are located in a qualifying country (for details, see
Band 1 and 2 eligible countries at http://www.who.int/hinari/eligibility/en/). Other-
wise, page charges will not be waived, except for solicited editorials.
Approval of Fees and Invoicing: A summary of publication charges (figures,
tables, and supplemental data) will be presented to the corresponding author of
accepted manuscripts for approval prior to publication; final page charges cannot
be determined until final publication. Color figure charges will not be waived, but
color figures may be published in black and white, pending editorial approval.
Requests for black and white figure publication must be made prior to execution
of the publication charge approval form to avoid color charges. A final invoice will
be presented immediately after publication; full payment is expected at that time.
Open Choice. In addition to publication charges outlined above, authors may
elect to participate in the Journal’s OpenChoice program. Articles published under
Open Choice will become immediately accessible on the Journal website upon
publication, without the twelve-month subscriber-only access delay. Authors wish-
ing to participate should contact the Editorial Office following manuscript accep-
tance. All copyright restrictions regarding reuse still apply. Cost to participate is
$3000, which must be received before article restriction is lifted.
Reprints. Reprints should be ordered when page proofs are returned; an order
form is included with the proofs. Late reprint orders may result in additional fees.
Author reprints will be supplied in CMYK color mode because it is a printed
medium, but electronic reprints will be supplied in RGB color mode for visualiza-
tion on screen. There is no extra charge for color reprints. Each coauthor will
receive one complimentary electronic (secure PDF) reprint. Additional electronic
reprints can be ordered at the time page proofs are returned or at a later date. No
hardcopy complimentary reprints are provided by the publisher.
Proofs. The corresponding author will be contacted by email once proofs are
ready, and will be directed to download electronic proofs from a secure website.
Electronic page proofs will be provided in RGB, thus reflecting the online quality.
Image files will be converted to CMYK for the printed journal; all images published
online will be in RGB. Full instructions on completing proof corrections will be
provided with the downloaded proof. The author should check the proofs carefully,
mark any printer’s errors, and answer queries as requested. Author changes
should be kept to a minimum. Proof corrections and replacement figures (if any)
must be returned within 48 hours to avoid any delay in publication.
Cover Figure. The cover figure is selected by the Editors from illustrations
appearing in the current issue. Authors are encouraged to suggest a figure for
consideration or include an additional cover figure submission along with their
manuscript submission. Cover figures are published at no charge; cover reprints
are available as cover stock reprints or posters (no complimentary cover reprints
are provided by the publisher).
Editorial Communications. All correspondence concerning editorial matters
should be addressed to the Editor-in-Chief at The American Journal of Pathology,
9650 Rockville Pike, Bethesda, Maryland, USA 20814-3993, faxed to 301-634-
7961, or emailed to ajp@asip.org. Appeals (rebuttals) to editorial decisions must
be submitted within 60 days to be considered. Letters to the Editor will be printed
at the Editors’ discretion in the Correspondence section.
Corrections are published upon request and after editorial review. Retractions
are published upon request of authors or their institutions and may also be
published by the Journal following a determination of scientific misconduct. Notes
of Concern are published in response to editorial concerns relating to scientific or
publishing misconduct by authors or reviewers or to alert the scientific community
of an ongoing investigation.
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